Innoviva (INVA) EV to CFO (2015 - 2026)
Innoviva's (INVA) EV to CFO stood at 5.59 in Q2 2026, up 46.0% from 3.83 a year earlier but down 7.4% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) EV to CFO (2015 - 2026) Analysis & Trends
On a TTM basis, Innoviva's EV to CFO came in at -3.35 as of Jun 30, 2026; for FY2025, it came in at 4.70, up 31.4% from FY2024.
- Across earlier years, EV to CFO came in at 3.58 in FY2024 (-38.6%), 5.83 in FY2023 (+87.9%), 3.10 in FY2022 (+1.7%) and 3.05 in FY2021 (-11.4%).
- Quarterly EV to CFO has ranged from 1.98 in Q1 2023 to 6.03 in Q1 2026 over the past five years.
- On a year-over-year basis, EV to CFO has increased for three consecutive quarters, with growth averaging 12.2% over the last six quarters.
- Peak year-over-year performance for EV to CFO in the last five years was growth of 118.5% in Q1 2024, against a decline of 45.5% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 6.03 (Q1 2026), 4.70 (Q4 2025) and 4.12 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Innoviva | 1.54 Bn | -745.98 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.59 |
| Mar 31, 2026 | 6.03 |
| Dec 31, 2025 | 4.70 |
| Sep 30, 2025 | 4.12 |
| Jun 30, 2025 | 3.83 |
| Mar 31, 2025 | 3.45 |
| Dec 31, 2024 | 3.58 |
| Sep 30, 2024 | 5.66 |
| Jun 30, 2024 | 5.59 |
| Mar 31, 2024 | 4.33 |
| Jun 30, 2023 | 2.73 |
| Mar 31, 2023 | 1.98 |
| Jun 30, 2022 | 2.48 |
| Mar 31, 2022 | 3.43 |
| Dec 31, 2021 | 3.05 |
| Sep 30, 2021 | 3.18 |
| Jun 30, 2021 | 3.67 |
| Mar 31, 2021 | 3.06 |
| Dec 31, 2020 | 3.44 |
| Sep 30, 2020 | 2.14 |
API Access
Innoviva EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();